Fortis Malar Hospitals Ltd.

62.45 -0.58 ▼-0.9%

05 December 2023, 04:01:00 PM
Volume: 35,450

Company Profile

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.fortismalar.com
Market Cap 117.04 Cr.
Enterprise Value(EV) 87.28 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -6.86 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 64.08 Trailing Twelve Months Ending 2023-09
Book Value / Share 31.65 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.97 Calculated using Price: 62.45
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.87 Cr. 18,741,759 Shares
FaceValue 10
About Fortis Malar Hospitals Ltd.
Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder's vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care.

Fortis Malar Hospitals Ltd. Delivery

Delivered Qty
Traded Qty

Fortis Malar Hospitals Ltd. Performance

1 Day
-0.92%
1 Week
-9.74%
1 Month
-17.61%
3 Month
+5.85%
6 Month
+24.97%
1 Year
+9.56%
2 Year
+0.48%
5 Year
+7.67%
10 Year
+177.56%

Fortis Malar Hospitals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.93 6.80 3.16 3.28 1.97 -8.82 -8.50 -9.80 -21.46
Return on Capital Employed (%) 14.17 10.96 5.00 5.90 3.17 -4.09 -4.44 -2.02 -1.30
Return on Assets (%) 6.85 4.97 2.40 2.40 1.39 -5.27 -4.51 -5.29 -10.66

Fortis Malar Hospitals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 91 98 100 103 105 96 89 80 64 59
Non Curr. Liab. 0 0 0 0 0 56 47 41 42 38
Curr. Liab. 37 32 30 45 44 36 25 31 32 31
Minority Int.
Equity & Liab. 128 130 130 148 149 188 161 152 138 129
Non Curr. Assets 20 28 33 34 37 126 101 103 54 52
Curr. Assets 108 102 97 113 112 62 60 49 84 77
Misc. Exp. not W/O
Total Assets 128 130 130 148 149 188 161 152 138 129

Fortis Malar Hospitals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 118 130 141 149 145 112 69 86 86 78
Other Income 8 9 8 8 10 11 8 7 7 7
Total Income 126 138 149 158 155 123 78 94 93 86
Total Expenditure -110 -124 -140 -147 -147 -115 -76 -83 -81 -77
PBIDT 15 14 9 10 8 8 2 11 11 9
Interest -1 0 0 0 -1 -8 -7 -7 -6 -6
Depreciation -3 -3 -4 -4 -4 -13 -13 -13 -12 -12
Taxation -4 -4 -1 -2 -1 3 3 0 -8 -5
Exceptional Items -1 7
PAT 8 6 3 3 2 -9 -8 -8 -15 -13
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 8 6 3 3 2 -9 -8 -8 -15 -13
Adjusted EPS 4 3 2 2 1 -5 -4 -4 -8 -7

Fortis Malar Hospitals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 4 10 -9 9 -16 0 -1 7 6
Cash Fr. Inv. -1 5 -22 13 -2 6 50 -28 8 1
Cash Fr. Finan. -1 -1 -1 0 0 -12 -7 -10 -13
Net Change 3 10 -13 4 7 -9 38 -36 5 -7
Cash & Cash Eqvt 6 16 3 7 15 5 43 7 12 6

Fortis Malar Hospitals Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71
Public 37.29 37.29 37.29 37.29 37.29 37.29 37.29 37.29 37.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Fortis Malar Hospitals Ltd. Announcements

Tue, 05 Dec 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI(LODR) Regulation 2015 please find enclosed copies of newspaper advertisements published on December 5 2023. Detailed disclosure is enclosed
Mon, 04 Dec 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015 the Company is in receipt of intimation regarding loss of share certificate/issuance of duplicate share certificates as details enclosed.
Mon, 04 Dec 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In compliance with Regulation 30 of SEBI (LODR) Regulations 2015 this is to inform you that the company has completed the dispatch of postal ballot notice to its members on December 4 2023 for seeking approval on the resolutions as detailed in postal ballot notice as enclosed.

Fortis Malar Hospitals Ltd. Technical Scans

Tue, 05 Dec 2023
Opening at High Opening at High
Close Below Last Month Low Close Below Last Month Low
Opening at High for 2 Days Opening at High for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 6 Months High Increase in 6 Months

Fortis Malar Hospitals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,541.53 1,240.10 +0.7%
Divi's Laboratories Ltd. 99,355.60 3,744.50 -1.4%
Cipla Ltd. 98,827.76 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. 96,346.31 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. 80,129.03 5,569.05 -1.0%
Mankind Pharma Ltd. 78,038.63 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. 71,060.00 2,101.30 -1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.81 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 74.60 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-09 28.62 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.92 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.88 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 60.88 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.27 2,101.30 -1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 7.84 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-09 3.98 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.78 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.33 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 9.26 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.59 2,101.30 -1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,101.30 -1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.30 -1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.30 -1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,101.30 -1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,101.30 -1.4%

Fortis Malar Hospitals Ltd. FAQ's

What is Fortis MalarHospital share price?

Can I buy Fortis MalarHospital shares now?

What is the Market Cap of Fortis MalarHospital?

What are the key metrics to analyse Fortis MalarHospital?

What is the 52 Week High and Low of Fortis MalarHospital?

What is the trend of Fortis MalarHospital share price?